Tyra Biosciences, Inc.
TYRA • NASDAQ
Tyra Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Todd Harris, with a market cap of $2.0B.
CEOTodd Harris
Next Earnings
Upcoming earnings announcement for Tyra Biosciences, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.59
Earnings History
Past 12 earnings reports for Tyra Biosciences, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Q4 2025 | -$0.57Est: -$0.53 | -7.5% | - | — |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.50Est: -$0.51 | +2.0% | - | — | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.47Est: -$0.52 | +9.6% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.47Est: -$0.47 | 0.0% | - | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.43Est: -$0.46 | +6.5% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.41Est: -$0.40 | -2.5% | - | — | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.32Est: -$0.41 | +22.0% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.35Est: -$0.43 | +18.6% | - | — | 10-Q |
| Mar 19, 2024 | Q4 2023 | -$0.53Est: -$0.48 | -10.4% | - | — | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.49Est: -$0.35 | -40.0% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.31Est: -$0.34 | +8.8% | - | — | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.28Est: -$0.37 | +24.3% | - | — | — |